A phase II trial of omadacycline for the treatment of complicated urinary tract infections
Phase of Trial: Phase II
Latest Information Update: 03 Apr 2017
At a glance
- Drugs Omadacycline (Primary)
- Indications Urinary tract infections
- Focus Proof of concept; Therapeutic Use
- Sponsors Paratek Pharmaceuticals
- 03 Apr 2017 According to a Paratek Pharmaceuticals media release, company plans to begin enrolment as early as December of 2017.
- 08 Feb 2017 According to a Paratek Pharmaceuticals media release, company plans to begin enrolment in the fourth quarter of 2017.
- 06 May 2016 New trial record